Capital International Investors 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:32 pm Purchase | 2024-12-31 | 13G | Sarepta Therapeutics, Inc. SRPT | Capital International Investors | 8,896,223 9.300% | 2,532,633 (+39.80%) | Filing |
| 2024-11-13 10:27 am Purchase | 2024-11-14 | 13G | Sarepta Therapeutics, Inc. SRPT | Capital International Investors | 6,363,590 6.700% | 1,622,105 (+34.21%) | Filing |
| 2024-02-09 6:05 pm Purchase | 2024-02-07 | 13G | Sarepta Therapeutics, Inc. SRPT | Capital International Investors | 4,741,485 5.100% | 4,741,485 (New Position) | Filing |